Clinical Trial Update: Conversational Agents to Improve HPV Vaccine Acceptance in Primary Care (ECA-HPV)- Clinical Trial [NA]

View source ↗

Summary

A clinical trial evaluating the use of conversational agents to improve HPV vaccine acceptance in primary care has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection

Snippet

Sponsor: Tufts Medical Center | Conditions: Human Papilloma Virus | NA | Status: TERMINATED